ASPN

UniProt ID: Q9BXN1
Organism: Homo sapiens
Review Status: COMPLETE
πŸ“ Provide Detailed Feedback

Gene Description

Asporin (ASPN, also PLAP-1) is a secreted extracellular matrix protein of the small leucine-rich repeat family. Unlike related SLRPs, it lacks a glycosaminoglycan attachment site, and it carries a polymorphic N-terminal aspartate repeat that binds calcium. It binds type I collagen, competing with decorin, and binds TGF-beta, inhibiting TGF-beta-induced chondrogenesis and matrix gene expression in articular cartilage. The D14 repeat allele, which inhibits most strongly, is associated with osteoarthritis. In the periodontal ligament it blocks BMP-2 binding to its type IB receptor, preventing ligament mineralization. In osteoblast cultures it promotes collagen mineralization.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005509 calcium ion binding
IDA
PMID:19589127
Asporin competes with decorin for collagen binding, binds ca...
ACCEPT
Summary: Calcium ion binding (IDA). The polyaspartate stretch of asporin binds calcium and regulates hydroxyapatite formation in vitro. Accepted.
Reason: [PMID:19589127 "We demonstrate that the polyaspartate domain binds calcium and regulates hydroxyapatite formation in vitro."]
Supporting Evidence:
PMID:19589127
We demonstrate that the polyaspartate domain binds calcium and regulates hydroxyapatite formation in vitro.
GO:0005576 extracellular region
IBA
GO_REF:0000033
ACCEPT
Summary: Extracellular region (IBA). Asporin is a secreted extracellular matrix protein of the small leucine-rich repeat family. Accepted.
Reason: [file:human/ASPN/ASPN-uniprot.txt "CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular"] [PMID:19589127 "Here, we show that asporin binds collagen type I."]
Propagation Review
Root cause: NO FAILURE CORE
Sources checked:
PANTHER:PTN002542430 SUPPORTS TRANSFER
SLRP family node seeded by many characterized secreted leucine-rich repeat proteins, human ASPN (Q9BXN1) among them; extracellular location is conserved.
Supporting Evidence:
file:human/ASPN/ASPN-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
PMID:19589127
Here, we show that asporin binds collagen type I.
GO:0030021 extracellular matrix structural constituent conferring compression resistance
RCA
PMID:20551380
Proteomics characterization of extracellular space component...
MARK AS OVER ANNOTATED
Summary: Extracellular matrix structural constituent conferring compression resistance (RCA, from an extracellular-space proteomics study). Matrisome pipelines assign this term to proteoglycans, whose glycosaminoglycan chains give compression resistance. Asporin has no glycosaminoglycan attachment site and is probably not a proteoglycan; its known ECM role is binding collagen and growth factors. The term overstates its structural role; marked as over-annotated.
Reason: [file:human/ASPN/ASPN-uniprot.txt "CC attachment of O-linked glycosaminoglycans and this is probably not a"] [PMID:19589127 "Here, we show that asporin binds collagen type I."]
Supporting Evidence:
file:human/ASPN/ASPN-uniprot.txt
CC attachment of O-linked glycosaminoglycans and this is probably not a
PMID:19589127
Here, we show that asporin binds collagen type I.
GO:0030021 extracellular matrix structural constituent conferring compression resistance
RCA
PMID:25037231
Extracellular matrix signatures of human primary metastatic ...
MARK AS OVER ANNOTATED
Summary: Extracellular matrix structural constituent conferring compression resistance (RCA, from a colon cancer ECM proteomics study). Matrisome pipelines assign this term to proteoglycans, whose glycosaminoglycan chains give compression resistance. Asporin has no glycosaminoglycan attachment site and is probably not a proteoglycan; its known ECM role is binding collagen and growth factors. The term overstates its structural role; marked as over-annotated.
Reason: [file:human/ASPN/ASPN-uniprot.txt "CC attachment of O-linked glycosaminoglycans and this is probably not a"] [PMID:19589127 "Here, we show that asporin binds collagen type I."]
Supporting Evidence:
file:human/ASPN/ASPN-uniprot.txt
CC attachment of O-linked glycosaminoglycans and this is probably not a
PMID:19589127
Here, we show that asporin binds collagen type I.
GO:0030021 extracellular matrix structural constituent conferring compression resistance
RCA
PMID:27068509
Extracellular matrix remodelling in response to venous hyper...
MARK AS OVER ANNOTATED
Summary: Extracellular matrix structural constituent conferring compression resistance (RCA, from a venous ECM proteomics study). Matrisome pipelines assign this term to proteoglycans, whose glycosaminoglycan chains give compression resistance. Asporin has no glycosaminoglycan attachment site and is probably not a proteoglycan; its known ECM role is binding collagen and growth factors. The term overstates its structural role; marked as over-annotated.
Reason: [file:human/ASPN/ASPN-uniprot.txt "CC attachment of O-linked glycosaminoglycans and this is probably not a"] [PMID:19589127 "Here, we show that asporin binds collagen type I."]
Supporting Evidence:
file:human/ASPN/ASPN-uniprot.txt
CC attachment of O-linked glycosaminoglycans and this is probably not a
PMID:19589127
Here, we show that asporin binds collagen type I.
GO:0030021 extracellular matrix structural constituent conferring compression resistance
RCA
PMID:27559042
Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin...
MARK AS OVER ANNOTATED
Summary: Extracellular matrix structural constituent conferring compression resistance (RCA, from a muscle ECM glycoproteomics study). Matrisome pipelines assign this term to proteoglycans, whose glycosaminoglycan chains give compression resistance. Asporin has no glycosaminoglycan attachment site and is probably not a proteoglycan; its known ECM role is binding collagen and growth factors. The term overstates its structural role; marked as over-annotated.
Reason: [file:human/ASPN/ASPN-uniprot.txt "CC attachment of O-linked glycosaminoglycans and this is probably not a"] [PMID:19589127 "Here, we show that asporin binds collagen type I."]
Supporting Evidence:
file:human/ASPN/ASPN-uniprot.txt
CC attachment of O-linked glycosaminoglycans and this is probably not a
PMID:19589127
Here, we show that asporin binds collagen type I.
GO:0030021 extracellular matrix structural constituent conferring compression resistance
RCA
PMID:28675934
Characterization of the Extracellular Matrix of Normal and D...
MARK AS OVER ANNOTATED
Summary: Extracellular matrix structural constituent conferring compression resistance (RCA, from a matrisome proteomics atlas of normal and diseased tissues). Matrisome pipelines assign this term to proteoglycans, whose glycosaminoglycan chains give compression resistance. Asporin has no glycosaminoglycan attachment site and is probably not a proteoglycan; its known ECM role is binding collagen and growth factors. The term overstates its structural role; marked as over-annotated.
Reason: [file:human/ASPN/ASPN-uniprot.txt "CC attachment of O-linked glycosaminoglycans and this is probably not a"] [PMID:19589127 "Here, we show that asporin binds collagen type I."]
Supporting Evidence:
file:human/ASPN/ASPN-uniprot.txt
CC attachment of O-linked glycosaminoglycans and this is probably not a
PMID:19589127
Here, we show that asporin binds collagen type I.
GO:0030282 bone mineralization
IDA
PMID:19589127
Asporin competes with decorin for collagen binding, binds ca...
KEEP AS NON CORE
Summary: Bone mineralization (IDA). Asporin binds calcium through its polyaspartate domain and increases collagen nodule formation and osteoblast markers in culture. Its effect on mineralization is context-dependent, as it inhibits periodontal ligament mineralization. Kept as non-core.
Reason: [PMID:19589127 "We demonstrate that the polyaspartate domain binds calcium and regulates hydroxyapatite formation in vitro."] [PMID:19589127 "In the presence of asporin, the number of collagen nodules, and mRNA of osteoblastic markers Osterix and Runx2, were increased."] [PMID:17522060 "We report that PLAP-1/asporin is also expressed specifically and predominantly in the periodontal ligament (PDL) and that it negatively regulates the mineralization of PDL cells."]
Supporting Evidence:
PMID:19589127
We demonstrate that the polyaspartate domain binds calcium and regulates hydroxyapatite formation in vitro.
PMID:19589127
In the presence of asporin, the number of collagen nodules, and mRNA of osteoblastic markers Osterix and Runx2, were increased.
PMID:17522060
We report that PLAP-1/asporin is also expressed specifically and predominantly in the periodontal ligament (PDL) and that it negatively regulates the mineralization of PDL cells.
GO:0030512 negative regulation of transforming growth factor beta receptor signaling pathway
IDA
PMID:17827158
Mechanisms for asporin function and regulation in articular ...
ACCEPT
Summary: Negative regulation of transforming growth factor beta receptor signaling pathway (IDA). Asporin binds TGF-beta directly and inhibits TGF-beta-induced matrix gene expression and chondrogenesis in human articular chondrocytes. It acts by sequestering the ligand from its receptor. Core process.
Reason: [PMID:15640800 "In vitro binding assays showed a direct interaction between asporin and TGF-beta."] [PMID:17827158 "Asporin inhibits TGF-beta/Smad signaling upstream of TGF-beta type I receptor activation in vivo by co-localizing with TGF-beta1 on the cell surface and blocking its interaction with the TGF-beta type II receptor."] [PMID:17827158 "Asporin blocks chondrogenesis and inhibits TGF-beta1-induced expression of matrix genes and the resulting chondrocyte phenotypes."]
Supporting Evidence:
PMID:15640800
In vitro binding assays showed a direct interaction between asporin and TGF-beta.
PMID:17827158
Asporin inhibits TGF-beta/Smad signaling upstream of TGF-beta type I receptor activation in vivo by co-localizing with TGF-beta1 on the cell surface and blocking its interaction with the TGF-beta type II receptor.
PMID:17827158
Asporin blocks chondrogenesis and inhibits TGF-beta1-induced expression of matrix genes and the resulting chondrocyte phenotypes.
GO:0030512 negative regulation of transforming growth factor beta receptor signaling pathway
IEA
GO_REF:0000107
ACCEPT
Summary: Negative regulation of transforming growth factor beta receptor signaling pathway (IEA). Asporin binds TGF-beta directly and inhibits TGF-beta-induced matrix gene expression and chondrogenesis in human articular chondrocytes. It acts by sequestering the ligand from its receptor. Core process.
Reason: [PMID:15640800 "In vitro binding assays showed a direct interaction between asporin and TGF-beta."] [PMID:17827158 "Asporin inhibits TGF-beta/Smad signaling upstream of TGF-beta type I receptor activation in vivo by co-localizing with TGF-beta1 on the cell surface and blocking its interaction with the TGF-beta type II receptor."] [PMID:17827158 "Asporin blocks chondrogenesis and inhibits TGF-beta1-induced expression of matrix genes and the resulting chondrocyte phenotypes."]
Propagation Review
Root cause: NO FAILURE CORE
Sources checked:
UniProtKB:Q99MQ4 SUPPORTS TRANSFER
Mouse Aspn (UniProtKB:Q99MQ4); human ASPN has its own IDA (PMID:17827158).
Supporting Evidence:
PMID:15640800
In vitro binding assays showed a direct interaction between asporin and TGF-beta.
PMID:17827158
Asporin inhibits TGF-beta/Smad signaling upstream of TGF-beta type I receptor activation in vivo by co-localizing with TGF-beta1 on the cell surface and blocking its interaction with the TGF-beta type II receptor.
PMID:17827158
Asporin blocks chondrogenesis and inhibits TGF-beta1-induced expression of matrix genes and the resulting chondrocyte phenotypes.
GO:0031012 extracellular matrix
HDA
PMID:20551380
Proteomics characterization of extracellular space component...
ACCEPT
Summary: Extracellular matrix (HDA; detected in an extracellular-space proteomics study). Asporin is an ECM component of cartilage and periodontal ligament that binds type I collagen. Core location.
Reason: [PMID:19589127 "Here, we show that asporin binds collagen type I."] [file:human/ASPN/ASPN-uniprot.txt "CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular"]
Supporting Evidence:
PMID:19589127
Here, we show that asporin binds collagen type I.
file:human/ASPN/ASPN-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
GO:0031012 extracellular matrix
HDA
PMID:25037231
Extracellular matrix signatures of human primary metastatic ...
ACCEPT
Summary: Extracellular matrix (HDA; detected in a colon cancer ECM proteomics study). Asporin is an ECM component of cartilage and periodontal ligament that binds type I collagen. Core location.
Reason: [PMID:19589127 "Here, we show that asporin binds collagen type I."] [file:human/ASPN/ASPN-uniprot.txt "CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular"]
Supporting Evidence:
PMID:19589127
Here, we show that asporin binds collagen type I.
file:human/ASPN/ASPN-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
GO:0031012 extracellular matrix
HDA
PMID:27068509
Extracellular matrix remodelling in response to venous hyper...
ACCEPT
Summary: Extracellular matrix (HDA; detected in a venous ECM proteomics study). Asporin is an ECM component of cartilage and periodontal ligament that binds type I collagen. Core location.
Reason: [PMID:19589127 "Here, we show that asporin binds collagen type I."] [file:human/ASPN/ASPN-uniprot.txt "CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular"]
Supporting Evidence:
PMID:19589127
Here, we show that asporin binds collagen type I.
file:human/ASPN/ASPN-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
GO:0031012 extracellular matrix
HDA
PMID:27559042
Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin...
ACCEPT
Summary: Extracellular matrix (HDA; detected in a muscle ECM glycoproteomics study). Asporin is an ECM component of cartilage and periodontal ligament that binds type I collagen. Core location.
Reason: [PMID:19589127 "Here, we show that asporin binds collagen type I."] [file:human/ASPN/ASPN-uniprot.txt "CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular"]
Supporting Evidence:
PMID:19589127
Here, we show that asporin binds collagen type I.
file:human/ASPN/ASPN-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
GO:0031012 extracellular matrix
HDA
PMID:28675934
Characterization of the Extracellular Matrix of Normal and D...
ACCEPT
Summary: Extracellular matrix (HDA; detected in a matrisome proteomics atlas of normal and diseased tissues). Asporin is an ECM component of cartilage and periodontal ligament that binds type I collagen. Core location.
Reason: [PMID:19589127 "Here, we show that asporin binds collagen type I."] [file:human/ASPN/ASPN-uniprot.txt "CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular"]
Supporting Evidence:
PMID:19589127
Here, we show that asporin binds collagen type I.
file:human/ASPN/ASPN-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
GO:0031012 extracellular matrix
IDA
PMID:17827158
Mechanisms for asporin function and regulation in articular ...
ACCEPT
Summary: Extracellular matrix (IDA; shown in human articular cartilage). Asporin is an ECM component of cartilage and periodontal ligament that binds type I collagen. Core location.
Reason: [PMID:19589127 "Here, we show that asporin binds collagen type I."] [file:human/ASPN/ASPN-uniprot.txt "CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular"]
Supporting Evidence:
PMID:19589127
Here, we show that asporin binds collagen type I.
file:human/ASPN/ASPN-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
GO:0031012 extracellular matrix
IEA
GO_REF:0000107
ACCEPT
Summary: Extracellular matrix (IEA; projected from mouse Aspn). Asporin is an ECM component of cartilage and periodontal ligament that binds type I collagen. Core location.
Reason: [PMID:19589127 "Here, we show that asporin binds collagen type I."] [file:human/ASPN/ASPN-uniprot.txt "CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular"]
Propagation Review
Root cause: NO FAILURE CORE
Sources checked:
UniProtKB:Q99MQ4 SUPPORTS TRANSFER
Mouse Aspn (UniProtKB:Q99MQ4); human ASPN has its own ECM evidence.
Supporting Evidence:
PMID:19589127
Here, we show that asporin binds collagen type I.
file:human/ASPN/ASPN-uniprot.txt
CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
GO:0070171 negative regulation of tooth mineralization
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Negative regulation of tooth mineralization (IEA, from mouse Aspn). Asporin (PLAP-1) is expressed predominantly in the periodontal ligament and inhibits mineralization of PDL cells by blocking BMP-2 access to its receptor, keeping the ligament unossified. A tissue-specific outcome of its BMP antagonism; kept as non-core.
Reason: [PMID:17522060 "We report that PLAP-1/asporin is also expressed specifically and predominantly in the periodontal ligament (PDL) and that it negatively regulates the mineralization of PDL cells."] [PMID:18407830 "Recombinant PLAP-1/asporin inhibited BMP-2-induced cytodifferentiation of PDL cells and competitively prevented BMP-2 from binding to the BMP receptor-IB (BMPR-IB), resulting in inhibition of BMP-dependent activation of Smad proteins."]
Propagation Review
Root cause: NO FAILURE NON CORE
Sources checked:
UniProtKB:Q99MQ4 SUPPORTS TRANSFER
Mouse Aspn (UniProtKB:Q99MQ4); periodontal ligament mineralization.
Supporting Evidence:
PMID:17522060
We report that PLAP-1/asporin is also expressed specifically and predominantly in the periodontal ligament (PDL) and that it negatively regulates the mineralization of PDL cells.
PMID:18407830
Recombinant PLAP-1/asporin inhibited BMP-2-induced cytodifferentiation of PDL cells and competitively prevented BMP-2 from binding to the BMP receptor-IB (BMPR-IB), resulting in inhibition of BMP-dependent activation of Smad proteins.
GO:0070171 negative regulation of tooth mineralization
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: Negative regulation of tooth mineralization (ISS, from mouse Aspn). Asporin (PLAP-1) is expressed predominantly in the periodontal ligament and inhibits mineralization of PDL cells by blocking BMP-2 access to its receptor, keeping the ligament unossified. A tissue-specific outcome of its BMP antagonism; kept as non-core.
Reason: [PMID:17522060 "We report that PLAP-1/asporin is also expressed specifically and predominantly in the periodontal ligament (PDL) and that it negatively regulates the mineralization of PDL cells."] [PMID:18407830 "Recombinant PLAP-1/asporin inhibited BMP-2-induced cytodifferentiation of PDL cells and competitively prevented BMP-2 from binding to the BMP receptor-IB (BMPR-IB), resulting in inhibition of BMP-dependent activation of Smad proteins."]
Propagation Review
Root cause: NO FAILURE NON CORE
Sources checked:
UniProtKB:Q99MQ4 SUPPORTS TRANSFER
Mouse Aspn (UniProtKB:Q99MQ4); periodontal ligament mineralization.
Supporting Evidence:
PMID:17522060
We report that PLAP-1/asporin is also expressed specifically and predominantly in the periodontal ligament (PDL) and that it negatively regulates the mineralization of PDL cells.
PMID:18407830
Recombinant PLAP-1/asporin inhibited BMP-2-induced cytodifferentiation of PDL cells and competitively prevented BMP-2 from binding to the BMP receptor-IB (BMPR-IB), resulting in inhibition of BMP-dependent activation of Smad proteins.
GO:0140150 gel phase of interstitial matrix
IEA
GO_REF:0000117
MARK AS OVER ANNOTATED
Summary: Gel phase of interstitial matrix (IEA). This term denotes the hydrated aggrecan-hyaluronan gel of the interstitial matrix, built from glycosaminoglycan-bearing proteoglycans. Asporin has no glycosaminoglycan attachment site and is a collagen-fibril-binding protein, so it belongs with the fibrillar rather than the gel phase. The placement comes from a family-level proteoglycan grouping; marked as over-annotated.
Reason: [file:human/ASPN/ASPN-uniprot.txt "CC attachment of O-linked glycosaminoglycans and this is probably not a"] [PMID:19589127 "Here, we show that asporin binds collagen type I."]
Supporting Evidence:
file:human/ASPN/ASPN-uniprot.txt
CC attachment of O-linked glycosaminoglycans and this is probably not a
PMID:19589127
Here, we show that asporin binds collagen type I.
GO:0140150 gel phase of interstitial matrix
TAS
PMID:25701227
Proteoglycan form and function: A comprehensive nomenclature...
MARK AS OVER ANNOTATED
Summary: Gel phase of interstitial matrix (TAS). This term denotes the hydrated aggrecan-hyaluronan gel of the interstitial matrix, built from glycosaminoglycan-bearing proteoglycans. Asporin has no glycosaminoglycan attachment site and is a collagen-fibril-binding protein, so it belongs with the fibrillar rather than the gel phase. The placement comes from a family-level proteoglycan grouping; marked as over-annotated.
Reason: [file:human/ASPN/ASPN-uniprot.txt "CC attachment of O-linked glycosaminoglycans and this is probably not a"] [PMID:19589127 "Here, we show that asporin binds collagen type I."]
Supporting Evidence:
file:human/ASPN/ASPN-uniprot.txt
CC attachment of O-linked glycosaminoglycans and this is probably not a
PMID:19589127
Here, we show that asporin binds collagen type I.
GO:1902617 response to fluoride
IEA
GO_REF:0000107
UNDECIDED
Summary: Response to fluoride (IEA, from rat). An Ensembl orthology projection of a rat observation that cannot be checked from the cached sources. At most it reflects transcript regulation, with no known role for the protein in a fluoride response. Undecided.
Reason: The row is an Ensembl orthology projection from rat; no cached evidence connects asporin to a fluoride response.
Propagation Review
Root cause: SOURCE WEAK OR INFERRED
Sources checked:
UniProtKB:A0A1W2Q6A1 SOURCE WEAK OR INFERRED
Rat Aspn projection; source evidence not available in the cache.
GO:0050431 transforming growth factor beta binding
IDA
PMID:15640800
An aspartic acid repeat polymorphism in asporin inhibits cho...
NEW
Summary: Transforming growth factor beta binding (NEW, IDA). In vitro binding assays show a direct interaction between asporin and TGF-beta, and the D14 repeat allele inhibits TGF-beta activity most strongly. This binding is the basis of its inhibition of TGF-beta signalling. Comparators: other non-receptor TGF-beta-sequestering proteins carry this term, including LTBP1, LTBP3, LTBP4, LRRC32 (GARP) and WFIKKN2 (QuickGO, 2026-10-05).
Reason: [PMID:15640800 "In vitro binding assays showed a direct interaction between asporin and TGF-beta."] [PMID:15640800 "Asporin suppresses TGF-beta-mediated expression of the genes aggrecan (AGC1) and type II collagen (COL2A1) and reduced proteoglycan accumulation in an in vitro model of chondrogenesis."]
Supporting Evidence:
PMID:15640800
In vitro binding assays showed a direct interaction between asporin and TGF-beta.
PMID:15640800
Asporin suppresses TGF-beta-mediated expression of the genes aggrecan (AGC1) and type II collagen (COL2A1) and reduced proteoglycan accumulation in an in vitro model of chondrogenesis.
GO:0005518 collagen binding
IDA
PMID:19589127
Asporin competes with decorin for collagen binding, binds ca...
NEW
Summary: Collagen binding (NEW, IDA). Asporin binds type I collagen through its leucine-rich repeats 10-12, competing with decorin.
Reason: [PMID:19589127 "Here, we show that asporin binds collagen type I."]
Supporting Evidence:
PMID:19589127
Here, we show that asporin binds collagen type I.

Core Functions

Secreted SLRP that binds TGF-beta and sequesters it from its receptor, inhibiting TGF-beta signalling in cartilage.

Supporting Evidence:
  • PMID:15640800
    In vitro binding assays showed a direct interaction between asporin and TGF-beta.
  • PMID:17827158
    Asporin inhibits TGF-beta/Smad signaling upstream of TGF-beta type I receptor activation in vivo by co-localizing with TGF-beta1 on the cell surface and blocking its interaction with the TGF-beta type II receptor.
  • PMID:17827158
    Asporin blocks chondrogenesis and inhibits TGF-beta1-induced expression of matrix genes and the resulting chondrocyte phenotypes.

Type I collagen-binding extracellular matrix protein.

Supporting Evidence:
  • PMID:19589127
    Here, we show that asporin binds collagen type I.
  • PMID:19589127
    We demonstrate that the polyaspartate domain binds calcium and regulates hydroxyapatite formation in vitro.

Calcium binding by the N-terminal polyaspartate stretch.

Molecular Function:
calcium ion binding
Supporting Evidence:
  • PMID:19589127
    We demonstrate that the polyaspartate domain binds calcium and regulates hydroxyapatite formation in vitro.

References

Loading supporting content…

Download this section (compressed HTML)

Suggested Questions for Experts

Q: Does asporin's sequestration of BMP-2 from BMPR-IB, shown in periodontal ligament cells, operate in human tissues, and should negative regulation of BMP signaling be annotated once human evidence is available?

Q: How does the aspartate-repeat length tune asporin's binding of TGF-beta, BMP-2 and calcium, and which of these underlies the osteoarthritis association?

Suggested Experiments

Experiment: Compare D13 and D14 asporin for TGF-beta and BMP-2 binding affinity and for calcium-dependent collagen mineralization in chondrocyte and PDL cultures.

Deep Research

Affinage

(ASPN-deep-research-affinage.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“š Additional Documentation

Notes

(ASPN-notes.md)

ASPN notes

  • TGF-beta binding PMID:15640800 is a NEW IDA. Comparator: LTBP1/3/4, LRRC32 and WFIKKN2 carry GO:0050431 (QuickGO 2026-10-05). Decorin does not, so it is not cited as a comparator.
  • Collagen binding (PMID:19589127) is a NEW IDA.
  • The five matrisome RCA "compression resistance" rows and the two gel-phase rows are over-annotated: UniProt notes no GAG attachment site, so it is probably not a proteoglycan, and asporin is a collagen-fibril binder. The rat-projected fluoride row is UNDECIDED.
  • BMP-2 antagonism (PMID:17522060, PMID:18407830) is captured through the tooth-mineralization row and the description. No BMP-binding NEW row is added, because species and assay details are abstract-only.
  • The FGF-2, TLR2/4, HIF-1alpha and adipogenesis PLAP-1 studies are not cached and not used.

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)